Sastasundar Ventures: Is Their B2B Pivot Finally Paying Off? Q1 FY26 Earnings Revealed

Published: Aug 19, 2025 02:10

Sastasundar Ventures Limited, a player in India’s digital healthcare ecosystem, has just unveiled its Q1 FY26 earnings, offering a nuanced look at a company in transition. While the top-line saw modest growth, a deeper dive into the numbers reveals a strategic pivot that’s reshaping its revenue mix and profitability landscape. Is this the turning point investors have been waiting for, or are there still hurdles to overcome? Let’s break it down.

A Tale of Two Segments: Revenue Dynamics Under Scrutiny

At first glance, Sastasundar Ventures’ Revenue from Operations in Q1 FY26 saw a respectable 5.9% year-on-year (YoY) increase, reaching Rs. 278.5 Crores. However, a slight 1.2% sequential dip from Q4 FY25 hints at ongoing rebalancing within its business verticals. The real story lies beneath this aggregate figure, in the shifting contributions of its core segments.

Table: Breakup of Revenue (Vertical) (Rs. Crs)

Particulars (Rs. Crs) Q1 FY26 Q1 FY25 Q4 FY25 FY25 FY24
Supply chain
SastaSundar (B2C) 33.3 75.2 26.1 143.7 863.2
Retailer Shakti (B2B) 244.5 186.8 255.1 941.3 488.6
Diagnostic 0.7 0.9 0.7 3.1 3.0
Healthcare Network 278.5 262.9 281.9 1,088.1 1,354.8
Financial Services 19.9 7.4 3.9 22.8 21.0
Total Revenue 298.4 270.3 285.8 1,111.0 1,375.7

The most striking change is the pronounced pivot from its B2C SastaSundar segment to the B2B Retailer Shakti platform. The B2C segment’s revenue dramatically shrank by over 50% YoY, from Rs. 75.2 Crores in Q1 FY25 to Rs. 33.3 Crores in the current quarter. This suggests a strategic de-emphasis or a challenging competitive environment for direct-to-consumer operations.

Conversely, the Retailer Shakti (B2B) segment has emerged as the clear growth engine, surging by a robust 30.9% YoY to Rs. 244.5 Crores. This segment now accounts for the lion’s share of the company’s operational revenue, underlining a successful shift towards powering smaller retailers. The slight QoQ dip in Retailer Shakti from Q4 FY25’s Rs. 255.1 Crores warrants observation, but the overall trend is clear: Sastasundar is increasingly a B2B supply chain facilitator.

Adding another interesting layer, Financial Services income more than doubled YoY, jumping from Rs. 7.4 Crores to Rs. 19.9 Crores. This segment, though smaller, is rapidly growing and significantly contributes to the ‘Other Income’ line item, which we’ll discuss next.

The shift towards B2B aligns well with India’s domestic growth themes, especially with strong infrastructure and manufacturing policy momentum. This strategic pivot could potentially offer more stable, higher-volume revenue streams compared to the more volatile B2C e-pharmacy space.

The Path to Profitability: Unpacking Earnings

While revenue composition is evolving, the journey to sustainable profitability remains the central narrative for Sastasundar.

Table: Q1 FY26 Consolidated Profit & Loss Statement (Rs. Crs)

Particulars (Rs. Crs) Q1 FY26 Q1 FY25 Y-o-Y Q4 FY25 Q-o-Q FY 24-25 FY 23-24
Revenue from Operations 278.5 263.0 5.9% 281.9 (1.2%) 1,088.5 1,355.2
Cost of Materials Consumed 257.6 242.7 265.3 1017.4 1232.8
Gross Profit 20.9 20.3 3.0% 16.6 25.9% 71.1 122.4
GP % 7.5% 7.7% 5.9% 6.5% 9.0%
Employee Benefits Expense 17.3 10.6 16.3 49.8 49.0
Other Expenses 17.4 19.4 29.4 99.8 88.5
EBITDA (13.8) (9.7) (29.1) (78.5) (15.1)
EBITDA % (5.0%) (3.7%) (10.3%) (7.2%) (1.1%)
Other Income# 45.3 35.1 25.5 82.3 81.0
Depreciation and Amortisation Expense 1.2 1.6 1.3 5.8 9.1
EBIT 30.3 23.7 (4.9) (2.0) 56.7
Profit for the period/Year 26.6 50.0 17.6 (122.7) 92.0

The Gross Profit (GP) saw a healthy 25.9% QoQ jump, reaching Rs. 20.9 Crores, with GP% improving from 5.9% to 7.5%. This is a positive sign, indicating better underlying product margins or more efficient procurement compared to the immediate prior quarter. However, the GP% is still below Q1 FY25’s 7.7%, suggesting room for further optimization.

The core operating profitability, measured by EBITDA, remains in the red at (Rs. 13.8 Crores). This is a worsening from (Rs. 9.7 Crores) in Q1 FY25. However, the crucial change here is the significant QoQ improvement from the much deeper loss of (Rs. 29.1 Crores) in Q4 FY25. This suggests that while operating expenses (Employee Benefits and Other Expenses) are still high relative to revenue, the management has made strides in reining them in, leading to a narrower operating loss margin of (5.0%) from (10.3%) last quarter. This indicates improved operational efficiency.

The star performer for the bottom line, however, is “Other Income,” which swelled to Rs. 45.3 Crores in Q1 FY26, up sharply from Rs. 25.5 Crores in Q4 FY25 and Rs. 35.1 Crores in Q1 FY25. The presentation explicitly states this includes “financial service income.” This substantial other income is the primary driver behind the positive EBIT of Rs. 30.3 Crores and PBT of Rs. 30.2 Crores, converting what would otherwise be a significant operational loss into a profit.

While relying heavily on “other income” for overall profitability isn’t ideal for a sustainable business model, the fact that it’s largely driven by “financial service income” (which is a growth vertical for the company) makes it a more integrated part of their strategy rather than a one-off. Investors should closely watch if the company can transition its core healthcare network operations to profitability, reducing reliance on financial services.

Ultimately, Profit for the period (PAT) stood at Rs. 26.6 Crores. This marks a decrease from Rs. 50.0 Crores in Q1 FY25, mainly due to a higher tax expense in Q1 FY26 and the absence of an associate loss seen in Q1 FY25. However, it’s a positive sequential turnaround from Rs. 17.6 Crores in Q4 FY25, again driven by the improving core operations and strong other income.

Given the current dynamics, Sastasundar Ventures appears to be a “Turnaround” story. It’s not yet a fast or super grower based on overall profitability, but the significant improvements in QoQ EBITDA and the growth in its B2B segment signal a strategic direction aimed at achieving sustainable growth and eventual core profitability.

Capital Efficiency and Financial Health: A Solid Foundation

Despite the operational shifts and profitability challenges, Sastasundar Ventures demonstrates commendably strong working capital management and liquidity.

Table: Working Capital (No of Days)

Working Capital (No of Days) Q1FY25 Q2FY25 Q3FY25 Q4FY25 Q1FY26
Inventory 40 37 37 35 36
Receivable 16 14 12 7 6
Payable 21 19 19 19 11
Working Capital (No of Days) 36 32 30 23 32
Working Capital % of Revenue 10% 9% 8% 6% 9%
Working Capital ₹ cr 103 93 92 73 95

The company’s working capital days have shown an impressive 12% YoY reduction, moving from 36 days in Q1 FY25 to 32 days in Q1 FY26. While there was a slight uptick from Q4 FY25’s low of 23 days, the overall trend points to improved efficiency in managing inventory and receivables. Specifically, Receivable days have consistently declined, indicating faster cash collection, and Payable days also saw a significant drop in Q1 FY26, suggesting quicker payments to suppliers, which could impact supplier relations but also indicates tight cash management.

The balance sheet further reinforces a strong financial position. Sastasundar maintains Liquid Assets (Bank Balance, Fixed Deposits, Investments in Mutual Funds etc.) of Rs. 655 Crores in Q1 FY26. This substantial liquidity, coupled with virtually no external borrowings (Finance Costs are negligible at Rs. 0.1 Cr), gives the company significant flexibility to fund its growth initiatives and navigate operational fluctuations without immediate external financing needs. Capital Work-in-Progress (Rs. 10.2 Cr) indicates modest ongoing CapEx for growth.

The management’s assertion that “Growth acting as Catalyst for reduction in Working Capital requirement” resonates with the B2B model, where higher turnover can often lead to better working capital cycles.

Investment Insight & Outlook

Sastasundar Ventures Limited presents an intriguing case for investors. The strategic shift away from a capital-intensive, perhaps less profitable, B2C model towards the more scalable B2B Retailer Shakti platform seems to be a prudent move. This aligns with the broader Indian economic narrative of strong domestic demand and emphasis on supply chain efficiency.

For future earnings, the key drivers will be:

  1. Sustained Growth in Retailer Shakti: Can the B2B segment continue its robust growth trajectory? If so, it could significantly scale revenue with potentially better unit economics than B2C.
  2. Path to Core Operational Profitability: While the QoQ EBITDA improvement is encouraging, turning the core healthcare network business (excluding financial services) profitable is crucial for long-term value creation. Investors will be watching for sustained reductions in employee benefits and other expenses relative to revenue growth.
  3. Leveraging Financial Services: The high growth in financial services income is clearly a strategic asset. Can the company further integrate this with its core healthcare network to create synergistic value?

The company’s robust liquidity and efficient working capital management provide a strong foundation. This allows management to focus on executing its strategic shift without immediate financial pressures. However, given the overall negative profitability over recent years (as seen in the FY25 net loss) and the reliance on ‘Other Income’, Sastasundar fits the profile of a “Turnaround” opportunity. Success hinges on management’s ability to consistently deliver improving core operational metrics alongside its strategic pivot.

Key Takeaways: